Cansortium (CNTMF) Stock Price, News & Analysis

Company Overview

Cansortium, Inc. (OTCMKTS:CNTMF) is a vertically integrated cannabis company engaged in the cultivation, manufacturing, distribution and retail of medical cannabis products in the United States. The company’s operations span from seed to sale, with dedicated cultivation facilities, extraction labs and a network of dispensaries serving registered patients.

Cansortium holds licenses and operates in multiple jurisdictions, including Florida, Pennsylvania, Louisiana, Texas and Puerto Rico. Its product portfolio encompasses cannabis flower, pre-rolls, concentrates, vape cartridges, oils, edibles and topicals, offered under brands such as The+Source, Chroma and Campfire, alongside its private-label formulations.

Founded in 2017 and headquartered in Miami, Cansortium began dispensary operations in Florida in 2018 and has since expanded its footprint into new markets. The company has invested in high-intensity cultivation infrastructure and advanced manufacturing processes to ensure product consistency and supply reliability. Leadership is headed by CEO Daniel O’Connell, who has overseen the company’s growth strategy and digital retail initiatives.

Key Stats

• Today's Range: $0.05 to $0.05
• 50-Day Range: $0.05 to $0.08
• 52-Week Range: $0.04 to $0.19
• Volume: 120,089 shs
• Average Volume: 234,993 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CNTMF Stock Analysis - Frequently Asked Questions

How have CNTMF shares performed this year?

Cansortium's stock was trading at $0.0728 at the beginning of 2025. Since then, CNTMF shares have decreased by 29.9% and is now trading at $0.0510.

How do I buy shares of Cansortium?

Shares of CNTMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CNTMF
• CIK: 1758124
• Web: www.cansortium.com
• Phone: (305) 441-9085
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A